DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,046 filers reported holding DANAHER CORPORATION in Q3 2016. The put-call ratio across all filers is 0.17 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $7,947,000 | -0.7% | 102,100 | 0.0% | 0.55% | -3.2% |
Q3 2016 | $8,004,000 | -22.4% | 102,100 | 0.0% | 0.57% | -23.6% |
Q2 2016 | $10,312,000 | +6.5% | 102,100 | 0.0% | 0.75% | +2.6% |
Q1 2016 | $9,685,000 | +1.4% | 102,100 | -0.7% | 0.73% | +0.4% |
Q4 2015 | $9,548,000 | +9.0% | 102,800 | 0.0% | 0.72% | +6.5% |
Q3 2015 | $8,760,000 | -0.4% | 102,800 | 0.0% | 0.68% | +13.5% |
Q2 2015 | $8,799,000 | +0.7% | 102,800 | -0.1% | 0.60% | +3.5% |
Q1 2015 | $8,734,000 | -0.9% | 102,870 | 0.0% | 0.58% | -1.0% |
Q4 2014 | $8,817,000 | +12.8% | 102,870 | 0.0% | 0.58% | +4.5% |
Q3 2014 | $7,816,000 | -3.5% | 102,870 | 0.0% | 0.56% | -2.3% |
Q2 2014 | $8,099,000 | +4.9% | 102,870 | -0.0% | 0.57% | 0.0% |
Q1 2014 | $7,718,000 | -2.8% | 102,905 | 0.0% | 0.57% | -3.9% |
Q4 2013 | $7,944,000 | +11.1% | 102,905 | -0.2% | 0.60% | -2.0% |
Q3 2013 | $7,151,000 | +9.5% | 103,155 | 0.0% | 0.61% | -6.5% |
Q2 2013 | $6,530,000 | – | 103,155 | – | 0.65% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |
BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |